Countries Japan
Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide ...
April 12, 2024 | News
Nanoform Finland Plc ("Nanoform") announced a strategic partnership whereby CBC Co., Ltd. ("CBC"), will utilize its extensive experience in the Japan...
April 12, 2024 | News
ACROBiosystems has been continuously rolling out a series of innovative organoid-related products. At a range of significant international events, includin...
April 11, 2024 | News
Eisai Co., Ltd. and Biogen Inc. have taken a significant step forward in the fight against Alzheimer’s disease by submitting a Supplemental Biologics...
April 01, 2024 | News
Resonance Health Ltd, listed on the Australian Securities Exchange (ASX) under the ticker RHT, has officially announced its strategic move into the Japanes...
March 28, 2024 | News
Takeda Receives FDA Approval for ICLUSIG as a First-Line Treatment in Ph+ ALL Takeda Pharmaceutical Company Limited (TSE: 4502; NYSE: TAK) is plea...
March 25, 2024 | News
This approval marks a pioneering step in treating adult patients with newly diagnosed Philadelphia chromosome-positive (Ph+) ALL, offering a combination th...
March 20, 2024 | News
Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, received CDMO Le...
March 13, 2024 | News
Ono Pharmaceutical announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University&nbs...
March 12, 2024 | News
Eisai Co., Ltd. announced a significant step forward in the fight against Alzheimer's disease (AD) today, with its U.S. subsidiary Eisai Inc. committing up...
March 07, 2024 | News
While they are identified and addressed differently around the world, there are over known 6,000 rare diseases – characterized by a wide range of dis...
February 29, 2024 | News
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") has announced a strategic partnership with the AI-driven company InveniAI...
February 22, 2024 | News
Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas") announced that Japan's Ministry of Health, Labour a...
February 19, 2024 | News
Approval based primarily on results from Phase 3 trial showing Dupixent significantly reduced itch compared to placebo CSU is the fifth appr...
February 17, 2024 | News
Most Read
Bio Jobs
News
Editor Picks